This could account for the higher detection rate of CBFB rearrangement (16.6%) by FISH in our cohort than the reported 5% of inv(16)/t(16;16) by conventional cytogenetics only in all AML cases [3]. The gene discussed is CBFB; the disease is acute myeloid leukemia.